Biomarkers for predicting postoperative complications following anatomic lung resectio

Recruiting

• Conditions: In this prospective study we assess the predictive ability of B-type natriuretic peptide (BNP) and lactate for complications after anatomic lung rescection.; C34; Malignant neoplasm of bronchus and lung

• Registration Number: DRKS00014027
• Lead Sponsor: Abteilung für Thoraxchirurgie,Klinik Schillerhöhe,Robert-Bosch-KrankenhausProf. Dr. med. Godehard Friedel, Dr. med. Ruoyu Zhang

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Patients with confirmed or suspected lung cancer, who undergo anatomic lung resektion (pneumonectomy, lobectomy, Bi-lobectomy or segmentectomy) as elective surgery.

Exclusion Criteria

1. Lack of willingness to participate or capacity for consent,
2. Urgent or emergency surgery,
3. Redo surgery,
4. Age < 18,
5. Angina pectoris, myocardial infarction, pulmonary oedema, stroke or pneumonia in the last months.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is the cardiopulmonary complication 6 months following anatomic lung resection. Patient follow-up is carried out 6 weeks and 6 months following anatomic lung resection in the out-patient department.

Secondary Outcome Measures

Name	Time	Method
The secondary outcome is the overall morbidity 6 months following anatomic lung resection. Patient follow-up is carried out 6 weeks and 6 months following anatomic lung resection in the out-patient department.